Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar targetphil3 (< 20) Submitted: 11/12/2010 6:08:14 PM : Outperform Start Price: $4.15 SVA Score: -66.90

could be a multibagger, high insider ownership, 46% eps 3yrs, 43% rev. growth 3yrs, plus upcoming trials

Featured Broker Partners


Advertisement